Publications by authors named "Stephane Depil"

Claim this Profile
P
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7 immunorad conference.
Pierre-Antoine Laurent, Fabrice André, Alexandre Bobard, Desiree Deandreis, Sandra Demaria, Stephane Depil

Oncoimmunology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HERV-derived epitopes represent new targets for T-cell-based immunotherapies in ovarian cancer.
Paola Bonaventura, Audrey Page, Olivier Tabone, Yann Estornes, Virginie Mutez, Stéphane Depil

J Immunother Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2.
Candice Sakref, Alexis Saby, Céline Rodriguez, Maude Ardin, Lyvia Moudombi, Stéphane Depil

Nat Commun· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endogenous retroelements in hematological malignancies: From epigenetic dysregulation to therapeutic targeting.
Mohamed Chour, Françoise Porteu, Stéphane Depil, Vincent Alcazer

Am J Hematol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting heterochromatin eliminates chronic myelomonocytic leukemia malignant stem cells through reactivation of retroelements and immune pathways.
Donia Hidaoui, Audrey Porquet, Rabie Chelbi, Mathieu Bohm, Aikaterini Polyzou, Stéphane Depil

Commun Biol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of NK cell-based cancer immunotherapies through receptor engineering.
Audrey Page, Nicolas Chuvin, Jenny Valladeau-Guilemond, Stéphane Depil

Cell Mol Immunol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Netrin-1 blockade inhibits tumor associated Myeloid-derived suppressor cells, cancer stemness and alleviates resistance to chemotherapy and immune checkpoint inhibitor.
Benjamin Ducarouge, Anna-Rita Redavid, Camille Victoor, Ruxanda Chira, Aurélien Fonseca, Stéphane Depil

Cell Death Differ· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCR-engineered T cell therapy in solid tumors: State of the art and perspectives.
Estelle Baulu, Célia Gardet, Nicolas Chuvin, Stéphane Depil

Sci Adv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy as a means to increase the efficacy of T-cell therapy in solid tumors.
Pierre-Antoine Laurent, Daphne Morel, Lydia Meziani, Stephane Depil, Eric Deutsch

Oncoimmunology· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HERVs characterize normal and leukemia stem cells and represent a source of shared epitopes for cancer immunotherapy.
Vincent Alcazer, Paola Bonaventura, Laurie Tonon, Emilie Michel, Virginie Mutez, Stéphane Depil

Am J Hematol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour burden and antigen-specific T cell magnitude represent major parameters for clinical response to cancer vaccine and TCR-engineered T cell therapy.
Marion Mallet, Rasha E Boulos, Vincent Alcazer, Paola Bonaventura, Yann Estornes, Stéphane Depil

Eur J Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia.
Rim Trad, Walid Warda, Vincent Alcazer, Mathieu Neto da Rocha, Ana Berceanu, Stephane Depil

J Immunother Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy.
Paola Bonaventura, Vincent Alcazer, Virginie Mutez, Laurie Tonon, Juliette Martin, Stéphane Depil

Sci Adv· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[CD4 T Lymphocytes: major players in antitumor immune response].
Lucie Leclair, Stéphane Depil

Med Sci (Paris)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Development of allogeneic CAR T-cells].
Vincent Alcazer, Stéphane Depil

Bull Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[T cell-based immunotherapies in solid tumors].
Estelle Baulu, Aurore Dougé, Nicolas Chuvin, Jacques-Olivier Bay, Stéphane Depil

Bull Cancer· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Repurposing endogenous immune pathways to tailor and control chimeric antigen receptor T cell functionality.
Mohit Sachdeva, Brian W Busser, Sonal Temburni, Billal Jahangiri, Anne-Sophie Gautron, Stéphane Depil

Nat Commun· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human Endogenous Retroviruses (HERVs): Shaping the Innate Immune Response in Cancers.
Vincent Alcazer, Paola Bonaventura, Stephane Depil

Cancers (Basel)· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing endogenous immune pathways to tailor and control chimeric antigen receptor T cell functionality.
Mohit Sachdeva, Brian W Busser, Sonal Temburni, Billal Jahangiri, Anne-Sophie Gautron, Stéphane Depil

Nat Commun· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repurposing rotavirus vaccines for intratumoral immunotherapy can overcome resistance to immune checkpoint blockade.
Tala Shekarian, Eva Sivado, Anne-Catherine Jallas, Stéphane Depil, Janice Kielbassa

Sci Transl Med· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-Associated Fibroblasts Produce Netrin-1 to Control Cancer Cell Plasticity.
Pei-Ju Sung, Nicolas Rama, Jeromine Imbach, Stephany Fiore, Benjamin Ducarouge, Stephane Depil

Cancer Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of chimeric antigen receptor surface expression by a small molecule switch.
Alexandre Juillerat, Diane Tkach, Brian W Busser, Sonal Temburni, Julien Valton, Stéphane Depil

BMC Biotechnol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer vaccines: what's next?
Stéphane Depil, Paola Bonaventura, Vincent Alcazer

Oncotarget· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Granulocyte-macrophage colony-stimulating factor inactivation in CAR T-cells prevents monocyte-dependent release of key cytokine release syndrome mediators.
Mohit Sachdeva, Philippe Duchateau, Stéphane Depil, Laurent Poirot, Julien Valton

J Biol Chem· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis